Bio-Techne Corporation logo
TECHBio-Techne Corporation

Shares Outstanding: 156.94M

popular:market cap|pe ratio|revenue|price history|total return

The shares outstanding is 156.94M. It is below its 12-month average by 0.04% (157.00M).

Market Cap|Share Buybacks|EPS|All Metrics
Shares Outstanding

TECH Shares Outstanding

156.94M

Reported quarterly weighted average share count; no daily interpolation.

-4.19% 5Y
TECH Shares Outstanding

TECH Average Shares Outstanding Chart

TECH Shares Outstanding

TECH Current vs Average Shares Outstanding Chart

TECH Shares Outstanding Metrics

SHARES OUTSTANDING

156.94M

SHARES OUTSTANDING AVG TTM

157.00M

SHARES OUTSTANDING AVG 3Y

159.49M

SHARES OUTSTANDING AVG 5Y

161.25M

SHARES OUTSTANDING AVG 10Y

157.64M

SHARES OUTSTANDING AVG 15Y

154.59M

SHARES OUTSTANDING AVG 20Y

154.39M

CURRENT VS TTM AVG

-0.04%

CURRENT VS 3Y AVG

-1.60%

CURRENT VS 5Y AVG

-2.67%

CURRENT VS 10Y AVG

-0.44%

CURRENT VS 15Y AVG

+1.53%

CURRENT VS 20Y AVG

+1.65%

Share Structure

Shares Outstanding

157.52M

Float Shares

N/A

Stock Price

$71.00

Market Cap

$11.1B

Quarterly Shares Outstanding History

PeriodWeighted Average SharesQoQ Change
Q3 2026156.94M-0.04%
Q2 2025157.00M+0.41%
Q1 2025156.36M+0.39%
Q4 2025155.76M-2.01%
Q3 2025158.94M-1.05%
Q2 2024160.63M-0.30%
Q1 2024161.12M+0.29%
Q4 2024160.65M+0.10%
Q3 2024160.50M+0.27%
Q2 2023160.06M-1.16%
Q1 2023161.94M+0.01%
Q4 2023161.92M+0.19%
Q3 2023161.62M-0.08%
Q2 2022161.75M-0.26%
Q1 2022162.17M-0.87%
Q4 2022163.59M-0.18%
Q3 2022163.88M-0.58%
Q2 2021164.83M+0.12%
Q1 2021164.63M+0.51%
Q4 2021163.80M+0.67%
Q3 2021162.70M+1.04%
Q2 2020161.03M+0.58%
Q1 2020160.10M+0.82%
Q4 2020158.80M+0.67%
Q3 2020157.74M-0.29%
Q2 2019158.20M+0.76%
Q1 2019157.01M+0.30%
Q4 2019156.54M+0.71%
Q3 2019155.44M+0.29%
Q2 2018154.99M-0.17%
Q1 2018155.25M+1.22%
Q4 2018153.39M+0.54%
Q3 2018152.57M+0.57%
Q2 2017151.70M+0.59%
Q1 2017150.82M+0.42%
Q4 2017150.18M+0.14%
Q3 2017149.98M+0.04%
Q2 2016149.91M+0.01%
Q1 2016149.89M+0.24%
Q4 2016149.54M+0.23%
Q3 2016149.20M-0.01%
Q2 2015149.20M-0.04%
Q1 2015149.26M+0.05%
Q4 2015149.18M+0.07%
Q3 2015149.08M+0.16%
Q2 2014148.84M+0.17%
Q1 2014148.59M+0.11%
Q4 2014148.44M+0.15%
Q3 2014148.21M+0.10%
Q2 2013148.06M+0.24%
Q1 2013147.71M+0.00%
Q4 2013147.71M+0.05%
Q3 2013147.63M+0.02%
Q2 2012147.60M+0.01%
Q1 2012147.58M+0.00%
Q4 2012147.58M-0.09%
Q3 2012147.72M-0.26%
Q2 2011148.11M-0.38%
Q1 2011148.68M+0.00%
Q4 2011148.68M-0.06%
Q3 2011148.78M+0.10%
Q2 2010148.62M+0.13%
Q1 2010148.43M+0.00%
Q4 2010148.43M-0.73%
Q3 2010149.52M+0.07%
Q2 2009149.41M+0.04%
Q1 2009149.36M+0.00%
Q4 2009149.36M-0.43%
Q3 2009150.00M-1.30%
Q2 2008151.97M-1.95%
Q1 2008154.99M+0.00%
Q4 2008154.99M-0.92%
Q3 2008156.43M-0.98%
Q2 2007157.99M-0.23%
Q1 2007158.35M+0.00%
Q4 2007158.35M+0.11%
Q3 2007158.17M+0.08%
Q2 2006158.04M+0.11%
Q1 2006157.88M+0.00%
Q4 2006157.88M+0.11%
Q3 2006157.70M-0.85%
Q2 2005159.04M+0.23%
Q1 2005158.68M+0.00%
Q4 2005158.68M-3.00%
Q3 2005163.58M-1.88%
Q2 2004166.72M+0.01%
Q1 2004166.70M+0.00%
Q4 2004166.70M-0.18%
Q3 2004167.01M+0.24%
Q2 2003166.61M+0.13%
Q1 2003166.40M+0.00%
Q4 2003166.40M-0.93%
Q3 2003167.96M-0.77%
Q2 2002169.26M+0.07%
Q1 2002169.14M+0.00%
Q4 2002169.14M-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Shares Outstanding Formula & Definition

Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Shares Outstanding FAQ

What is the shares outstanding for Bio-Techne Corporation (TECH)?
The shares outstanding for TECH stock is 156.94M.
What is the TTM average shares outstanding for Bio-Techne Corporation (TECH)?
The TTM average shares outstanding for TECH stock is 157.00M.
What is the 3Y average shares outstanding for Bio-Techne Corporation (TECH)?
The 3Y average shares outstanding for TECH stock is 159.49M.
What is the 5Y average shares outstanding for Bio-Techne Corporation (TECH)?
The 5Y average shares outstanding for TECH stock is 161.25M.
What is the 10Y average shares outstanding for Bio-Techne Corporation (TECH)?
The 10Y average shares outstanding for TECH stock is 157.64M.
What is the 15Y average shares outstanding for Bio-Techne Corporation (TECH)?
The 15Y average shares outstanding for TECH stock is 154.59M.
What is the 20Y average shares outstanding for Bio-Techne Corporation (TECH)?
The 20Y average shares outstanding for TECH stock is 154.39M.

TECH Shares Outstanding History

DATESHARES OUTSTANDING
2026-03-31156.94M
2025-12-31157.00M
2025-09-30156.36M
2025-06-30155.76M
2025-03-31158.94M
2024-12-31160.63M
2024-09-30161.12M
2024-06-30160.65M
2024-03-31160.50M
2023-12-31160.06M
2023-09-30161.94M
2023-06-30161.92M
2023-03-31161.62M
2022-12-31161.75M
2022-09-30162.17M
2022-06-30163.59M
2022-03-31163.88M
2021-12-31164.83M
2021-09-30164.63M
2021-06-30163.80M
2021-03-31162.70M
2020-12-31161.03M
2020-09-30160.10M
2020-06-30158.80M
2020-03-31157.74M
2019-12-31158.20M
2019-09-30157.01M
2019-06-30156.54M
2019-03-31155.44M
2018-12-31154.99M
2018-09-30155.25M
2018-06-30153.39M
2018-03-31152.57M
2017-12-31151.70M
2017-09-30150.82M
2017-06-30150.18M
2017-03-31149.98M
2016-12-31149.91M
2016-09-30149.89M
2016-06-30149.54M
2016-03-31149.20M
2015-12-31149.20M
2015-09-30149.26M
2015-06-30149.18M
2015-03-31149.08M
2014-12-31148.84M
2014-09-30148.59M
2014-06-30148.44M
2014-03-31148.21M
2013-12-31148.06M
2013-09-30147.71M
2013-06-30147.71M
2013-03-31147.63M
2012-12-31147.60M
2012-09-30147.58M
2012-06-30147.58M
2012-03-31147.72M
2011-12-31148.11M
2011-09-30148.68M
2011-06-30148.68M
2011-03-31148.78M
2010-12-31148.62M
2010-09-30148.43M
2010-06-30148.43M
2010-03-31149.52M
2009-12-31149.41M
2009-09-30149.36M
2009-06-30149.36M
2009-03-31150.00M
2008-12-31151.97M
2008-09-30154.99M
2008-06-30154.99M
2008-03-31156.43M
2007-12-31157.99M
2007-09-30158.35M
2007-06-30158.35M
2007-03-31158.17M
2006-12-31158.04M
2006-09-30157.88M
2006-06-30157.88M
2006-03-31157.70M
2005-12-31159.04M
2005-09-30158.68M
2005-06-30158.68M
2005-03-31163.58M
2004-12-31166.72M
2004-09-30166.70M
2004-06-30166.70M
2004-03-31167.01M
2003-12-31166.61M
2003-09-30166.40M
2003-06-30166.40M
2003-03-31167.96M
2002-12-31169.26M
2002-09-30169.14M
2002-06-30169.14M

Related Metrics

Market CapShare BuybacksEPSAll Metrics

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN
3,100 employees
www.bio-techne.com
Healthcare / Biotechnology
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
View full financials